ERCO Pharma

ERCO Pharma is a Swedish private drug-delivery company focused on dermal and transdermal formulation development. The company appears to specialize in an in silico model of the human skin lipid barrier that is used to predict skin permeability and optimize topical and transdermal drug products. Publicly available information suggests ERCO Pharma operates primarily as a platform and formulation-enablement business rather than as a clinical-stage therapeutics developer with a disclosed proprietary pipeline. Its work has been described in connection with molecular dynamics modeling and support for development of new or improved dermal and transdermal formulations. Based on currently accessible sources, ERCO Pharma remains a small active company with limited public disclosure on partnered assets, financing, and commercial products.